The era of chemotherapy and IV tubes has given way to pills and outpatient monitoring. For patients with CML, the pill ...
A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...
A positive trend in overall survival was observed, favoring sacituzumab govitecan over chemotherapy, though data is still ...
Izalontamab (SI-B001), a novel EGFR/HER3 bispecific monoclonal antibody, was well-tolerated and exhibited preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback